Fumitoshi Hirayama Selected Research

Fumitoshi Hirayama Research Topics

Disease

3	Wounds and Injuries (Trauma) 03/2019 - 03/2015
3	Hemolysis 10/2011 - 10/2006
2	Neoplasms (Cancer) 05/2021 - 05/2006
2	Stroke (Strokes) 03/2021 - 12/2020
2	Alcoholic Fatty Liver 03/2021 - 12/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 11/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2017 - 02/2002
2	Dehydration (Water Stress) 01/2015 - 01/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2014 - 06/2012
2	Body Weight (Weight, Body) 06/2012 - 05/2006
1	Chronic Renal Insufficiency 01/2022
1	Inflammation (Inflammations) 03/2021
1	Fatty Liver 03/2021
1	Chronic Disease (Chronic Diseases) 02/2021
1	Obesity 01/2020
1	Hepatomegaly 03/2019
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 03/2019
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2019
1	Hypertension (High Blood Pressure) 02/2019
1	Renal Insufficiency (Renal Failure) 11/2018
1	Colitis 10/2017
1	Hyperphosphatemia 11/2014
1	Type 2 Diabetes Mellitus (MODY) 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2011
1	Diabetes Mellitus 01/2011
1	Septic Shock (Toxic Shock Syndrome) 11/2005
1	Vasculitis (Vasculitides) 12/2003
1	Thrombosis (Thrombus) 12/2003
1	Edema (Dropsy) 08/2002

Drug/Important Bio-Agent (IBA)

5	ChitosanIBA 02/2021 - 06/2012
4	Pharmaceutical PreparationsIBA 05/2021 - 10/2009
4	CyclodextrinsIBA 02/2019 - 10/2009
3	CholesterolIBA 12/2020 - 10/2011
3	ChitinIBA 12/2020 - 09/2016
3	Ether (Diethyl Ether)IBA 02/2019 - 09/2016
3	SolutionsIBA 05/2006 - 12/2003
2	sacranIBA 01/2022 - 03/2021
2	Polysaccharides (Glycans)IBA 01/2022 - 03/2021
2	TabletsIBA 02/2021 - 02/2019
2	Prednisolone (Predate)FDA LinkGeneric 10/2017 - 02/2002
2	limaprostIBA 01/2015 - 01/2014
2	Insulin Glargine (Lantus)FDA Link 10/2011 - 01/2011
1	Photosensitizing Agents (Photosensitizers)IBA 05/2021
1	TomatineIBA 05/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2021
1	LipidsIBA 03/2021
1	paramylonIBA 01/2020
1	Dietary Fiber FDA Link 01/2020
1	PolymersIBA 01/2020
1	tetrahydrocurcuminIBA 03/2019
1	Dronabinol (THC)FDA LinkGeneric 03/2019
1	Excipients (Suspending Agents)IBA 03/2019
1	Delayed-Action PreparationsIBA 02/2019
1	olmesartanIBA 02/2019
1	Therapeutic UsesIBA 10/2017
1	Dextran SulfateIBA 10/2017
1	Biocompatible Materials (Biomaterials)IBA 09/2016
1	GelsIBA 09/2016
1	Peroxynitrous Acid (Peroxynitrite)IBA 03/2015
1	hydroxide ionIBA 03/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2012
1	IndicanIBA 06/2012
1	CreatinineIBA 06/2012
1	Insulin (Novolin)FDA Link 10/2011
1	ONO2506IBA 07/2011
1	AcidsIBA 07/2011
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2011
1	alpha-cyclodextrinIBA 10/2006
1	(2-hydroxypropyl)-alpha-cyclodextrinIBA 10/2006
1	Liposomes (Liposome)IBA 05/2006
1	gamma-cyclodextrinIBA 05/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2006
1	dimethylacetyl-beta-cyclodextrinIBA 11/2005
1	LipopolysaccharidesIBA 11/2005
1	GalactosamineIBA 11/2005
1	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 12/2003
1	GlucocorticoidsIBA 02/2002

Therapy/Procedure

1	Nephrectomy 01/2022
1	Photochemotherapy (Photodynamic Therapy) 05/2021
1	Therapeutics 10/2017
1	Renal Dialysis (Hemodialysis) 11/2014
1	Intravenous Injections 05/2006
1	Intraperitoneal Injections 11/2005
1	Oral Administration 08/2002